Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus short magnesium sulfate infusion for ICU hypomagnesemia
IRCT20200322046833N4Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of magnesium sulfate in hypomagnesaemia (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Hypomagnesemia treatment protocol efficacy and Magnesium retention after treatment. Started Jan 2024; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
hypomagnesaemia
Beyond the preview
Go deeper on IRCT20200322046833N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200322046833N4.